FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
Back to search
Official data from USPTO
REVEAL GENOMICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/30/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
03/19/2021
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
02/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
ES
Examiner
HAN, DAWN
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "REVEAL" in blue and dark blue colors, the letter "A" of which appearing as a double helix design. Below this appears the stylized wording "GENOMICS" in dark blue color.
Holders and representatives
Holders
R. S. (pessoa física)
Representatives
Donna A. Tobin Royer Cooper Cohen Braunfeld LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic biomarker reagents for cancer diagnosisprognosis and treatment for medical purposes; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagentsclinical medical reagents; diagnostic reagents for medical use; diagnostic biomarker reagents for medical diagnostics
Class 42
Scientific research for medical purposes in oncology; research and development of biomarkers for cancer diagnosisprognosis and treatment
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2023
FIMP
FINAL DISPOSITION PROCESSED
05/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2022
PUBO
PUBLISHED FOR OPPOSITION
11/22/2022
GPNX
NOTIFICATION PROCESSED BY IB
11/21/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/26/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2022
RFNT
REFUSAL PROCESSED BY IB
12/19/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/02/2021
RFRR
REFUSAL PROCESSED BY MPU
12/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2021
CNRT
NON-FINAL ACTION WRITTEN
11/02/2021
DOCK
ASSIGNED TO EXAMINER
10/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens REVEAL GENOMICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.